108 related articles for article (PubMed ID: 29654889)
1. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
Song J; Wang T; Xu W; Wang P; Wan J; Wang Y; Zhan J; Zhang H
Cancer Lett; 2018 Jul; 426():63-72. PubMed ID: 29654889
[TBL] [Abstract][Full Text] [Related]
2. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma.
Sun X; Song J; Zhang J; Zhan J; Fang W; Zhang H
Front Med; 2020 Feb; 14(1):91-100. PubMed ID: 31372881
[TBL] [Abstract][Full Text] [Related]
3. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
4. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
5. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma.
Sha S; Gu Y; Xu B; Hu H; Yang Y; Kong X; Wu K
Dig Liver Dis; 2013 May; 45(5):422-9. PubMed ID: 23332081
[TBL] [Abstract][Full Text] [Related]
7. Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3.
Yuan L; Cheng F; Wu Z; Li X; Shen W
Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980
[TBL] [Abstract][Full Text] [Related]
8. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
[TBL] [Abstract][Full Text] [Related]
9. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
10. EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.
Sha MQ; Zhao XL; Li L; Li LH; Li Y; Dong TG; Niu WX; Jia LJ; Shao RG; Zhen YS; Wang Z
Cell Death Dis; 2016 Nov; 7(11):e2486. PubMed ID: 27882937
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
[TBL] [Abstract][Full Text] [Related]
12. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
[TBL] [Abstract][Full Text] [Related]
13. HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis.
Yao Y; Liu C; Wang B; Guan X; Fang L; Zhan F; Sun H; Li H; Lou C; Yan F; Lu X; Cui L; Liao Y; Han S; Yao Y; Zhang Y
Cancer Lett; 2022 May; 533():215595. PubMed ID: 35182659
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.
Deb P; Bhan A; Hussain I; Ansari KI; Bobzean SA; Pandita TK; Perrotti LI; Mandal SS
Gene; 2016 Sep; 590(2):234-43. PubMed ID: 27182052
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.
Huang K; Yuan R; Wang K; Hu J; Huang Z; Yan C; Shen W; Shao J
Chin J Cancer Res; 2014 Feb; 26(1):72-80. PubMed ID: 24653628
[TBL] [Abstract][Full Text] [Related]
16. EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy.
Liu Z; Yang L; Zhong C; Zhou L
J Cell Physiol; 2020 Feb; 235(2):1494-1503. PubMed ID: 31283006
[TBL] [Abstract][Full Text] [Related]
17. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
[TBL] [Abstract][Full Text] [Related]
18. Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.
Carbone C; Piro G; Simionato F; Ligorio F; Cremolini C; Loupakis F; Alì G; Rossini D; Merz V; Santoro R; Zecchetto C; Zanotto M; Di Nicolantonio F; Bardelli A; Fontanini G; Tortora G; Melisi D
Clin Cancer Res; 2017 Aug; 23(15):4312-4322. PubMed ID: 28298545
[No Abstract] [Full Text] [Related]
19. PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.
Wan J; Zhan J; Li S; Ma J; Xu W; Liu C; Xue X; Xie Y; Fang W; Chin YE; Zhang H
Nucleic Acids Res; 2015 Apr; 43(7):3591-604. PubMed ID: 25800736
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
